Health, Justice, and Economic Costs Associated with Drug Paraphernalia Policies in Wisconsin

Health, Justice, and Economic Costs Associated with Drug Paraphernalia Policies in Wisconsin

A Report by the Wisconsin Institute for Policy and Service
November 2026

Michael Klemp-North, PhD
Eric Giordano, PhD
Noah Colletti, MA

Read the Full Report

Overview

The purpose of this report is to analyze the health, justice system, and economic implications associated with Wisconsin’s drug paraphernalia policies and selected harm reduction strategies.

Drug overdose remains one of the most significant public health challenges facing Wisconsin and the nation. Policymakers, public health practitioners, and other stakeholders continue to debate the role of criminalization, harm reduction, treatment, and legal and public health strategies in response to these challenges.

By examining current burdens experienced across Wisconsin communities, including healthcare use, overdose mortality, criminal justice involvement, and related public costs, this report seeks to document current conditions and costs and inform policy considerations relevant to Wisconsin.

To view the full report, click here. See below for a summary of the key findings.

Key Findings: Health Outcomes and Costs

  • Drug overdose deaths remain a leading cause of preventable mortality in Wisconsin. In 2016, Wisconsin recorded 1,061 drug overdose deaths, reaching a peak of 1,830 in 2022, driven largely by the growing presence of fentanyl and an increasingly unpredictable drug supply. Since that peak, overdose deaths have declined to 1,185 in 2024, echoing the national trend.
  • Significant disparities exist in drug overdose mortality across racial and ethnic groups in Wisconsin. Black and American Indian/Alaska Native populations consistently experienced the highest overdose mortality rates in Wisconsin during the study period. American Indian and Alaska Native residents experienced the highest observed mortality rate, reaching 114.6 deaths per 100,000 residents in 2022.
  • Wisconsin’s drug overdose burden is centered in Milwaukee, but it affects communities throughout Wisconsin. Milwaukee County accounts for the largest total number of overdose deaths in Wisconsin, while Menominee County experienced the highest average annual overdose mortality from 2019–2023 (with Milwaukee a close second). Absolute counts and population-adjusted rates provide complementary perspectives on Wisconsin’s overdose burden and highlight the importance of local context when considering public health policy, prevention, and resource allocation.
  • Opioid- and stimulant-related emergency department visits and hospitalizations generate substantial healthcare expenditures annually. Together they represent some of the costliest health events examined in this report and contribute substantially to statewide healthcare expenditures. From 2016-2024, Wisconsin recorded approximately 88,388 drug-related emergency department visits, generating an estimated $107 million in emergency department charges alone. During roughly the same period, substance-related hospitalizations generated nearly $40 million in direct hospitalization costs.

Key Findings: Justice Outcomes and Costs

  • Paraphernalia enforcement continues to generate substantial court activity in Wisconsin. Wisconsin recorded 13,135 paraphernalia-related filings and 2,856 convictions in 2018, compared with 10,128 filings and 868 convictions in 2025.
  • Paraphernalia-related filings and convictions in Wisconsin generated an estimated $11.65 million to $33.01 million in criminal-legal costs statewide during 2024.
  • Direct justice system expenditures such as filings and convictions underestimate the broader economic burden associated with criminal-legal involvement. Detention and incarceration create substantial public expenditures beyond court processing costs as well as lost wages and productivity and other potential economic costs of criminal-legal involvement related to drug use.
  • Costs associated with drug paraphernalia-related detention are distributed unevenly across jurisdictions, particularly when examined relative to population size.
  • Criminal-legal involvement can influence both justice outcomes and health outcomes simultaneously. For example, Justice system involvement may contribute to elevated overdose risk following release.
  • Rural and urban communities experience different patterns of criminal-legal involvement. Rural counties accounted for approximately $9.27 million to $26.29 million in estimated costs compared with $2.35 million to $6.63 million in urban counties. Geographic context remains important for understanding enforcement and cost variation.

Key Findings: The Case of Milwaukee County

  • Milwaukee County accounts for a disproportionate share of Wisconsin’s overdose burden. For instance, Milwaukee County experiences substantially higher rates of drug-related emergency department utilization compared to the rest of Wisconsin.
  • While overdose mortality continues to have the largest aggregate effect on residents in and around Milwaukee, the overdose crisis is a statewide issue as well.
  • Milwaukee’s municipal and county ordinance framework focuses less on criminal prosecution, making it one of the few Wisconsin examples of meaningful variation in paraphernalia enforcement implementation.

Key Findings: Harm Reduction Strategies and Policy

  • Syringe Service Programs (SSPs) are established community-based access points for overdose prevention and recovery resources in Wisconsin. Greater utilization of SSPs is likely to reduce injection frequency over time, increase entry and retention in substance use treatment programs, and lead to positive downstream effects toward harm reduction.
  • Naloxone distribution reverses opioid overdoses and prevents overdose deaths and represents a core component of Wisconsin’s overdose response infrastructure.
  • Distribution of safer smoking supplies may offer a lower-cost harm reduction intervention than injection-focused supply distribution. Greater access to safer smoking supplies may reduce injection-related injuries and infections, provide a point of engagement with populations at elevated risk of overdose, and increase participation in harm reduction services.
  • The tenuous legal status of safer smoking supplies in Wisconsin illustrates how paraphernalia laws influence implementation of public health interventions. For instance, safer smoking supplies are not permitted for uses other than for tobacco under Wisconsin law, despite evidence that such products are less costly than alternative injection kits, are in greater demand by people who use drugs, and have fewer potential health complications.
  • Drug checking services improve awareness of drug contents and contaminants, support public health surveillance efforts, and provide early warning regarding changes in local drug supplies.
  • A realistic drug checking services model can be cost effective, including by reducing emergency department visits over time.

Recommendations

  • Improve Wisconsin’s Data Integration and Evaluation Capacity. Wisconsin maintains strong administrative datasets for measuring many downstream outcomes, including overdose mortality, emergency department utilization, hospitalizations, and court activity. However, significantly less information is available regarding service engagement, legal risk, treatment access, and behavioral responses. Future efforts should prioritize improved data sharing across agencies, enhanced integration of health and justice system datasets, expanded evaluation of public-health interventions and consistent statewide reporting standards.
  • Continue Monitoring Health and Justice Outcomes. The findings presented throughout this report demonstrate the value of regularly monitoring both health and justice system measures. Future monitoring efforts should include overdose mortality, hospitalizations, emergency department utilization, paraphernalia filings and convictions, criminal-legal system expenditures, and geographic disparities.
  • Expand Understanding of Local Implementation. Milwaukee County illustrates how local approaches to addressing drug paraphernalia may differ within a common statewide legal framework. Additional evaluation of local implementation approaches may improve understanding of how variations in enforcement, diversion practices, public health programming, and community resources relate to observed outcomes. Future research should continue examining local experiences while recognizing that demographic, economic, healthcare, and service-related factors may also influence outcomes.
  • Strengthen Public Health Infrastructure. The report highlights the importance of interventions that reduce harm before costly health or justice outcomes occur. Future efforts should focus on support for overdose-prevention initiatives, expanded opportunities for healthcare engagement, improved access to evidence-informed harm reduction services, and regular evaluation of emerging public health interventions.

Research Limitations

  • Analyses in this report are descriptive rather than causal. While associations between health outcomes, justice system outcomes, and public expenditures can be identified, the available data do not allow definitive conclusions regarding whether a specific policy directly caused the observed outcomes.
  • Important factors that may influence health and justice outcomes are not consistently captured in available datasets. Housing instability, transportation barriers, treatment access, healthcare engagement, stigma, and perceived legal risk can all influence outcomes but are difficult to measure systematically at the state level.
  • Wisconsin’s health and justice systems maintain separate administrative datasets. As a result, individuals cannot generally be followed across systems to determine how healthcare utilization, criminal-legal involvement, treatment participation, and other experiences interact over time.
  • Cost estimates included in this report rely upon established proxy measures and comparative costing methodologies. Wisconsin does not maintain comprehensive expenditure data specific to paraphernalia-related offenses. Estimates herein should therefore be interpreted as indicators of burden rather than audited fiscal totals.